13D Filing: Eses Holdings and Adamis Pharmaceuticals Corp (ADMP)

Page 2 of 9 – SEC Filing

CUSIP No. 00547W208 SCHEDULE 13D Page 2 of 9
1. Names of Reporting Persons.
I.R.S.  Identification Nos. of above persons (entities only).
Eses Holdings (FZE)
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a) ¨
(b) ¨
3. SEC Use Only
4. Source of Funds (See Instructions)
WC
5. Check if Disclosure of Legal Proceedings Is
Required Pursuant to Items 2(d) or 2(e) ¨
6. Citizenship or Place of Organization
Sharjah, United Arab Emirates
Number
of Shares
Beneficially
Owned
by Each
Reporting
Person
With
7. Sole Voting Power:
0
8. Shared Voting Power:
1,635,312 shares
9. Sole Dispositive Power:
0
10. Shared Dispositive Power:
1,635,312 shares
11. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,635,312 shares
12. Check if the Aggregate Amount in Row (11)
Excludes Certain Shares ¨ (See Instructions)
Not applicable.
13. Percent of Class Represented by Amount in Row (11):
10.8%  (See Item 5)
14. Type of Reporting Person (See Instructions)
CO

Follow Dmk Pharmaceuticals Corp (NASDAQ:DMK)